ANDRÉS
CANUT BLASCO
![Foto de ANDRÉS](/img/nophoto.png)
![Foto de GlaxoSmithKline (Spain)](/img/noimage_org.png)
GlaxoSmithKline (Spain)
Madrid, EspañaGlaxoSmithKline (Spain)-ko ikertzaileekin lankidetzan egindako argitalpenak (4)
2011
-
Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 3, pp. 167-173
2009
-
Impact of acute otitis media pathogen shifts on the clinical efficacy of several antibiotics: A therapeutic outcomes model
Journal of Chemotherapy, Vol. 21, Núm. 4, pp. 408-413
2007
-
What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model
Journal of Antimicrobial Chemotherapy, Vol. 60, Núm. 3, pp. 605-612
2005
-
Evaluation of antimicrobial treatments in children with acute otitis media in Spain: A pharmacokinetic-pharmacodynamic (PK/PD) approach
Journal of Chemotherapy, Vol. 17, Núm. 6, pp. 628-635